Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

Jack Meehan; Analyst; Nephron Research Erin Wright; Analyst; Morgan Stanley ...

During Q4 2024, global stocks were pressured by investor concerns about economic growth and persistent inflation in some regions & despite potential for further interest rate cuts in 2025.

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

According to LCH Investments, over 200 hedge funds are Tiger Cubs, funds started by former employees of Tiger Management, the ...

Q4 2024 Management View CEO Jim Davis reported a nearly 15% revenue growth for Q4, including 5% organic growth, and close to ...

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...